ST. LOUIS – Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, has partnered with management to acquire Seattle-based LifeSpan Biosciences, Inc., (LSBio). The Company is a founder-led developer and distributor of antibodies and related reagents primarily to the academic and pharmaceutical research markets via its e-commerce platform. Terms of the […]

UK-based Firm, Focused on Material-Property Testing, Joins James Heal in Group and Will Use New Resources to Fuel Growth BOSTON–Battery Ventures, a global technology investment firm, has reached an agreement for its platform in the material-property testing market, Physical Properties Testing* (PPT), to acquire Mecmesin,* a global supplier of force- and torque-testing equipment for consumer […]

TORONTO — Eurocontrol Technics Group Inc. (TSX Venture: EUO; OTCQB: EUCTF) (“Eurocontrol” or the “Company”), announces that it has entered into a share purchase agreement (the “Agreement”) with DYG Holdings Ltd. (the “Purchaser”), pursuant to which the Company has agreed to sell all of the shares of its Israeli subsidiaries to the Purchaser representing a […]

New York, New York – BelHealth Investment Partners, LLC (“BelHealth”), a New York-based healthcare private equity firm, announced today that it has acquired Gemini Bio-Products, Inc. (“Gemini” or the “Company”), a leading biological reagents manufacturer and supplier serving the scientific community across academic research and the biotechnology and biopharma industries. Founded in 1985 and headquartered […]

Pirana delivers faster, more efficient modeling and simulation results by connecting multiple tools, and providing an organizational and graphical environment for optimizing pharmacometrics workflow PRINCETON, NJ – Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, announced today that it has acquired Pirana, a widely used product for connecting […]

Los Angeles, CA – CalibreScientific® is pleased to announce that it has completed the acquisition of PhytoTechnology Laboratories, LLC (“PhytoTech Labs“ or the “Company”), a provider of products for plant molecular biology and plant tissue culture research sold throughout the world. Headquartered in Lenexa, Kansas, PhytoTech Labs is an industry leading provider with a diversified product […]

FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the sale of its Advanced Bioprocessing business to Thermo Fisher Scientific: “The sale of our Advanced Bioprocessing business will create greater focus for our Life Sciences segment where BD has outstanding opportunities to contribute significant […]

WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has signed a definitive agreement with BD (Becton, Dickinson and Company – NYSE: BDX), a leading global medical technology company, under which Thermo Fisher will acquire BD’s Advanced Bioprocessing business. This business combines a strong technical services program with a […]

Adds former Illumina operations team to develop and commercialize gene-editing technology Boulder, Colo. – Inscripta™, a leading gene-editing technology company, today announced the strategic acquisition of Solana Biosciences, a life sciences company founded by Illumina™ (NYSE: ILMN) veterans. Through the acquisition, Inscripta and Solana have joined forces to accelerate the commercialization of Inscripta’s suite of gene-editing […]

Männedorf, Switzerland – The Tecan Group (SIX Swiss Exchange: TECN) announced today that it has successfully completed the acquisition of NuGEN Technologies, Inc. (NuGEN) on August 31, 2018. On August 16, 2018, Tecan announced the acquisition of US-based NuGEN to further expand Tecan’s dedicated solutions offering into the new market segment of next-generation sequencing (NGS) reagents […]